Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

High Throughput Genomics, Inc

High Throughput Genomics (HTG) was founded to: Develop and market ArrayPlate measurement of gene expression, DNA and proteins.
Develop and market gene expression quantitative Nuclease Protection Assays (qNPA™).
Satisfy unmet needs encountered at all levels of drug discovery, clinical development, and clinical practice.
Other commercialized methods for drug discovery lack sensitivity and have poor reproducibility. As a result low and moderately expressed genes that change slightly but significantly in disease states cannot be identified accurately against background assay noise.
HTG introduced the ArrayPlate, its first qNPA product, to measure multiple gene expression targets simultaneously. The ArrayPlate combines the high sample throughput of traditional microplates with HTG's novel Universal Array™ technology, permitting investigators to customize the genes measured in each well using a simple bench-top[ reagent addition procedure, producing self-customized arrays. With the combination of these two technologies, researchers now have access to the excellent sensitivity required to detect small changes and weak activity and the reproducibility of conventional biochemical assays in a multiplexed format permitting the measurement of sets of from 2 to 128 or more genes for high volume profiling of gene expression. In practical terms, this combination provides sensitivity down to 1,000 cells on 0.01 micrograms of total RNA and exceptional reproducibility of 3% to 13% coefficient of variation (C.V.) across the entire assay for cellular in vitro and in vivo tissue assays. The ability to easily measure gene expression from fixed tissue with the same high quality as from cells or frozen tissue is unique to qNPA


Contact Details:
6296 E. Grant Road
Tucson
Arizona
85712
United States of America
Tel:(520) 547-2827
Fax:(520) 547-2837
Email:info@htgenomics.com
WWW:

www.htgenomics.com/




Loading...

BioNews Results for High Throughput Genomics, Inc:

SwitchGear Genomics launches novel high-throughput screening products for profiling biological pathway regulat
MTB Europe:  Oct 29 2009 10:36PM Matching: high throughput genomics inc
Eurogentec acquires California-based proteomics firm AnaSpec
PharmaBiz:  Oct 27 2009 8:27AM Matching: high throughput genomics inc
Eurogentec Announces Agreement to Acquire AnaSpec, Inc
PharmiWeb:  Oct 26 2009 4:16PM Matching: high throughput genomics inc
Eurogentec Announces Agreement to Acquire AnaSpec, Inc
NewsBlaze:  Oct 24 2009 4:12AM Matching: high throughput genomics inc
Eurogentec to acquire Anaspec, a private proteomics company in California
News-Medical.Net:  Oct 24 2009 4:36AM Matching: high throughput genomics inc
Promote your company here: BioNewsCast - Press Release Distribution

View more High Throughput Genomics, Inc news.

High Throughput Genomics, Inc Patents:

US Patent No.Title
6458533 High throughput assay system for monitoring ESTs
6238869 High throughput assay system

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 436 times since April 2007, the link to the organisation's website has been followed 58 times

Search for more companies in Tucson

Search for more companies in Arizona



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for High Throughput Genomics, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.